Teva Pharmaceutical Industries Limited · Drug Manufacturers - Specialty & Generic

TEVATeva Pharmaceutical Industries Limited

Reports 2026-11-03 · TueReaction day 11-04upcoming

Before the print · expectationsupdated nightly until T-1

Expected move (options)—from the event straddle
Actual vs expected, last 8Q—Lite and up
Short interest—Lite and up
Lean—Lite and up

Lean, evidence and peer references — Lite

The calendar is free. From the entry plan up you also get, for every ≥$1B reporter: the model lean with the evidence behind it, the peers that have already reported and how they traded, and the stock's own earnings history.

  • Lean and confidence, with the evidence rows that produced it
  • Per-peer reference table: each peer's own print, move and guidance
  • Expected-move band and the stock's last eight prints
Sign in / start free

The print · 8-K and callupcoming · 2026-11-03

Revenue—
est. $4.38B
EPS—
est. $0.74
Guidance—read from the 8-K once filed

Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →

Teva Pharmaceutical Industries earnings preview: what the record says

Teva Pharmaceutical Industries (TEVA) is scheduled to report earnings on Nov 3, 2026. The consensus estimate calls for EPS of $0.74 on revenue of $4.38B.

Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.

TEVA earnings: key questions

When is TEVA's next earnings date?

Teva Pharmaceutical Industries is scheduled to report on Nov 3, 2026.

What are TEVA's earnings expectations?

Analysts expect EPS of $0.74 on revenue of $4.38B for the quarter.